Show simple item record

dc.contributor.authorGonzález Ortega, Itxaso
dc.contributor.authorUgarte, Amaia
dc.contributor.authorRuiz de Azúa García, Sonia ORCID
dc.contributor.authorNúñez, Nuria
dc.contributor.authorZubia, Marta
dc.contributor.authorPonce, Sara
dc.contributor.authorCasla, Patricia
dc.contributor.authorLlano, Josu Xabier
dc.contributor.authorFaria, Ángel
dc.contributor.authorGonzález Pinto Arrillaga, Ana María ORCID
dc.date.accessioned2019-04-09T12:45:29Z
dc.date.available2019-04-09T12:45:29Z
dc.date.issued2016-12-22
dc.identifier.citationBMC Psychiatry 16 : (2016) // Article ID 452es_ES
dc.identifier.issn1471-244X
dc.identifier.urihttp://hdl.handle.net/10810/32387
dc.description.abstractBackground: Bipolar disorder patients frequently present recurrent episodes and often experience subsyndromal symptoms, cognitive impairment and difficulties in functioning, with a low quality of life, illness relapses and recurrent hospitalization. Early diagnosis and appropriate intervention may play a role in preventing neuroprogression in this disorder. New technologies represent an opportunity to develop standardized psychological treatments using internet-based tools that overcome some of the limitations of face-to-face treatments, in that they are readily accessible and the timing of therapy can be tailored to user needs and availability. However, although many psychological programs are offered through the web and mobile devices for bipolar disorder, there is a lack of high quality evidence concerning their efficacy and effectiveness due to the great variability in measures and methodology used. Methods: This clinical trial is a simple-blind randomized trial within a European project to compare an internet-based intervention with treatment as usual. Bipolar disorder patients are to be included and randomly assigned to one of two groups: 1) the experimental group (tele-care support) and 2) the control group. Participants in both groups will be evaluated at baseline (pre-treatment) and post-treatment. Discussion: This study describes the design of a clinical trial based on psychoeducation intervention that may have a significant impact on both prognosis and treatment in bipolar disorder. Specifically, bringing different services together (service aggregation), it is hoped that the approach proposed will significantly increase the impact of information and communication technologies on access and adherence to treatment, quality of the service, patient safety, patient and professional satisfaction, and quality of life of patients.es_ES
dc.description.sponsorshipThis study has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement No 604691.es_ES
dc.language.isoenges_ES
dc.publisherBiomed Centrales_ES
dc.relationinfo:eu-repo/grantAgreement/EC/FP7/604691es_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectbipolar disorderes_ES
dc.subjectpsychoeducationes_ES
dc.subjecttelemedicinees_ES
dc.subjectself-management interventiones_ES
dc.subjectgroup psychoeducationes_ES
dc.subjectspectrum disorderes_ES
dc.subjectillness activityes_ES
dc.subjectspanish versiones_ES
dc.subjectmental-healthes_ES
dc.subjectmood disorderes_ES
dc.subjectacceptabilityes_ES
dc.subjectfeasibilityes_ES
dc.subjectquestionnairees_ES
dc.titleOnline psycho-education to the treatment of bipolar disorder: protocol of a randomized controlled triales_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holderThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.es_ES
dc.rights.holderAtribución 3.0 España*
dc.relation.publisherversionhttps://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-016-1159-0es_ES
dc.identifier.doi10.1186/s12888-016-1159-0
dc.departamentoesNeurocienciases_ES
dc.departamentoeuNeurozientziakes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Except where otherwise noted, this item's license is described as This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.